New Retinal Surgery May Reverse Legal Blindness

An eye operation that moves the most light-sensitive part of the retina away from an underlying diseased area has saved sight in several people with a common, age-related eye disease.

The operation promises to save the vision of thousands of people threatened by age-related macular degeneration (AMD), the major cause of blindness in people over 55 years.

The technique, called macular translocation, is used in cases of AMD in which abnormal blood vessels grow and bleed underneath the retina, according to Eugene de Juan, M.D., professor of ophthalmology at the Wilmer Eye Institute. The growth of abnormal blood vessels occurs in choroid, the layer of blood vessels under the retina, causing the bleeding, or "wet" form of AMD.

"It's almost unheard of for someone with new blood vessels under the central retina caused by AMD to regain normal vision," says de Juan. "In contrast to the natural course of the disease, the vision in the eye of one of my patients improved after surgery from 20/160 to 20/30." A person with 20/160 vision sees clearly an object at 20 feet that a person with normal vision can see clearly at 160 feet. A vision of 20/20 is considered normal.

De Juan, who perfected the technique after modifying earlier, less successful surgical strategies, reports the results of the surgery in the first three patients in the May issue of the American Journal of Ophthalmology. He has now performed the same procedure on a total of 40, about 20 percent of whom have had their vision restored enough to read and drive.

"This technique gives us an important additional therapy used in conjunction with lasers," de Juan says. "The problem with treating the wet form of AMD with the laser is that you also destroy the functioning macula. That's like cutting off a leg to save your life. You end up alive but disabled."

In the new procedure, de Juan pinches the sclera, the white, outer part

Contact: Marc Kusinitz
Johns Hopkins Medical Institutions

Page: 1 2 3

Related biology news :

1. Continuing Research On Knee Surgery For Horses At Colorado State University Holds Promise Of Helping Humans With Osteoarthritis
2. Fetal Surgery For Spina Bifida Still Under Investigation At VUMC
3. Fully Endoscopic Brain Surgery At Cedars-Sinai Medical Center
4. Combination Therapy For Brain Tumors Holds Promise For Longer Survival After Surgery
5. Marylands Death Rate For Pancreatic Cancer Surgery Reduced By Medical Regionalization
6. Researchers Find Association Between Alzheimers Gene And Mental Impairment After Cardiac Surgery
7. Reverse-direction movement of a molecular motor
8. Reverse CPR performed on back could better restore blood flow
9. Key Peptides Found That Stop -- Even Reverse -- Kidney Disease In Lupus
10. Penn Researchers Develop Gene Therapy Technique That Reverses Muscle Membrane Weakness In Muscular Dystrophy Variant
11. Two-Pronged Attack On Immune System Cells Engineered By HIV Gene vpr: Effects Markedly Reversed By Antisteroid Compound RU-486

Post Your Comments:

(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences , ... life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer ... “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to ...
Breaking Biology Technology:
Cached News: